Lifestyle intervention
Lifestyle intervention (randomized arm)
LIFESTYLE
Related
Effects across outcomes
Bayesian random effects estimate against the comparator of each analysis (usually placebo), posterior median and 95% credible interval. Green: clearly better; red: clearly worse.
| Condition | Outcome | Window | Versus | Effect (95% CrI) | SUCRA |
|---|---|---|---|---|---|
| Overweight or obesity without diabetes (adults) | Serious adverse events | longest follow-up | Placebo | HR 4.99 (0.23 to 92.43) | 0.23 |
| Overweight or obesity without diabetes (adults) | Serious adverse events | longest follow-up | Placebo | HR 3.64 (0.17 to 67.53) | 0.31 |
| Overweight or obesity without diabetes (adults) | Nausea | longest follow-up | Placebo | HR 0.43 (0.08 to 1.70) | 0.93 |
| Overweight or obesity without diabetes (adults) | Nausea | longest follow-up | Placebo | HR 0.69 (0.11 to 2.58) | 0.86 |
| Overweight or obesity without diabetes (adults) | Vomiting | longest follow-up | Placebo | HR 0.53 (0.01 to 36.23) | 0.79 |
| Overweight or obesity without diabetes (adults) | Vomiting | longest follow-up | Placebo | HR 0.63 (0.01 to 40.29) | 0.79 |
| Overweight or obesity without diabetes (adults) | Diarrhea | longest follow-up | Placebo | HR 0.22 (0.02 to 1.45) | 0.93 |
| Overweight or obesity without diabetes (adults) | Diarrhea | longest follow-up | Placebo | HR 0.36 (0.03 to 2.32) | 0.88 |
| Overweight or obesity without diabetes (adults) | Constipation | longest follow-up | Placebo | HR 0.53 (0.01 to 37.00) | 0.69 |
| Overweight or obesity without diabetes (adults) | Constipation | longest follow-up | Placebo | HR 0.61 (0.01 to 41.21) | 0.68 |